Your search for "alzheimer" found 38 search results. Showing results 1 - 10 of 38.
Open Philanthropy recommended a grant of $800,000 over two years to the Massachusetts Eye and Ear Infirmary to support a multidisciplinary investigation of the mechanisms associated with resilience to Alzheimer’s disease. This includes the development of a drug that mimics the effects of the ApoE3ch allele, which has been reported to suppress early-onset Alzheimer’s. Read More
Open Philanthropy recommended a grant of £102,095 ($120,000 at the time of conversion) to the London School of Hygiene and Tropical Medicine to support epidemiological research, led by Professors Sinead Langhan and Charlotte Warren-Gash, on the impact of drugs used to treat psoriasis on Alzheimer’s risk. This follows Open Philanthropy’s … Read More
Open Philanthropy recommended a grant of $2,000,000 over three years to Washington University in St. Louis to support research led by Professor David Holtzman on how gut microbiomes affect Alzheimer’s pathology in mice. Recent results were published in Seo et al., Science 379, 155 (2023). This follows Good Ventures’ … Read More
Good Ventures awarded a grant of $4,500,000 over four years to Brigham and Women’s Hospital to support Professor David Walt’s work on developing methods for purifying and analyzing the composition of brain-derived exosomes from peripheral blood, as a possible method for diagnosing brain diseases such as Alzheimer’s. This follows Good… Read More
Good Ventures awarded a grant of $440,200 over four and a half years to the Universidad de Antioquia to support research on Alzheimer’s disease, led by Francisco Lopera of the Universidad de Antioquia, Diego Sepulveda-Falla of the Universitätsklinikum Hamburg-Eppendorf, Joseph Arboleda-Velásquez of Mass Eye and Ear, and Laura Kiessling and… Read More
Good Ventures awarded $1,000,000 over four and a half years to the Massachusetts Institute of Technology (MIT) to support research on Alzheimer’s disease, led by Laura Kiessling and Ed Boyden of MIT, Joseph Arboleda-Velásquez of Mass Eye and Ear, Diego Sepulveda-Falla of the Universitätsklinikum Hamburg-Eppendorf, and Francisco Lopera of the Universidad de Antioquia. Researchers… Read More
Good Ventures awarded a grant of $940,100 over four and a half years to Mass Eye and Ear to support research on Alzheimer’s disease, led by Joseph Arboleda-Velásquez of Mass Eye and Ear, Laura Kiessling and Ed Boyden of the Massachusetts Institute of Technology, Diego Sepulveda-Falla of the Universitätsklinikum Hamburg-Eppendorf,… Read More
Good Ventures awarded $1,300,000 over four and a half years to the Massachusetts Institute of Technology (MIT) to support research on Alzheimer’s disease, led by Laura Kiessling and Ed Boyden of MIT, Joseph Arboleda-Velásquez of Mass Eye and Ear, Diego Sepulveda-Falla of the Universitätsklinikum Hamburg-Eppendorf, and Francisco Lopera of the Universidad de Antioquia. Researchers… Read More
This gift is intended to support research into Alzheimer's and cardiovascular diseases. If infections are found to be a risk factor for cardiovascular or neurodegenerative disease, it would indicate that it might be worthwhile to initiate the development of vaccines for implicated viruses. This falls within Good Ventures' interest in… Read More
Good Ventures awarded a grant of $1,307,513 over four and a half years to the Universitätsklinikum Hamburg-Eppendorf (UKE) to support research on Alzheimer’s disease, led by Diego Sepulveda-Falla of UKE, Joseph Arboleda-Velásquez of Mass Eye and Ear, Laura Kiessling and Ed Boyden of the Massachusetts Institute of Technology, and Francisco… Read More